Response to letter “Perioperative Implications of Belzutifan Therapy in HIF2A-Related Pheochromocytoma and Paraganglioma”

Endocrine Practice · Published 2026-07-01 · DOI 10.1016/j.eprac.2026.07.009

Authors (2)

Hussam Alkaissi, Karel Pacak

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Alkaissi, H., Pacak, K. (2026). Response to letter “Perioperative Implications of Belzutifan Therapy in HIF2A-Related Pheochromocytoma and Paraganglioma”. Endocrine Practice. https://doi.org/10.1016/j.eprac.2026.07.009

Related articles

• Real-World Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Combination Therapy on Weight Management Within a Digital-Supported Shared Care Model for Type 2 Diabetes · Endocrine Practice · 2026 · Same journal
• Subclinical Thyroid Dysfunction in Pregnancy · Endocrine Practice · 2026 · Same journal
• Role of Nocturnal Cortisol and Catecholamines in the Pathophysiology of Nondipping Blood Pressure in Type 1 Diabetes Mellitus · Endocrine Practice · 2026 · Same journal
• Depressive Burden and Interoceptive Disturbance Improve After Bromocriptine Treatment in Women with Microprolactinomas · Endocrine Practice · 2026 · Same journal
• Treatment exposure and the 48-month threshold in prepregnancy dopamine agonist therapy for prolactinoma · Endocrine Practice · 2026 · Same journal
• MRI Phenotyping as a Tool for Early Detection of Hidden Hypercortisolism in Type 2 Diabetes · Endocrine Practice · 2026 · Same journal
• Phenotypic Characterization and rhGH Therapeutic Response in ACAN Children with Short Stature: A Real-World Study · Endocrine Practice · 2026 · Same journal
• Silent Bilateral Adrenal Incidental Pheochromocytomas: Time to Reconsider Routine Surgery? · Endocrine Practice · 2026 · Same journal
• Continuous Glucose Monitoring for Postkidney Transplantation in Patient With Pre-existing Type 2 Diabetes · Endocrine Practice · 2026 · Same journal
• Increased Risk of Venous Thromboembolism in Patients With Thyroid Eye Disease Compared to Graves’ Disease Without Orbitopathy · Endocrine Practice · 2026 · Same journal